Philadelphia Chromosome Positive (Ph+) Phase Chronic Myelogenous Leukemia (CML)
1 clinical trials · Condition
◉ Watch Philadelphia Chromosome Positive (Ph+) Phase Chronic Myelogenous Leukemia (CML)
| Record | Firm | Date |
|---|---|---|
| Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia (NCT02782403) | M.D. Anderson Cancer Center | 2017-03-20 |
Track Philadelphia Chromosome Positive (Ph+) Phase Chronic Myelogenous Leukemia (CML) automatically
Every clearance here is in the API, with alerts when new ones post.